Cargando…
Comprehensive analysis identifies novel targets of gemcitabine to improve chemotherapy treatment strategies for colorectal cancer
BACKGROUND: Gemcitabine (GEM) is a second-line anticancer drug of choice for some colorectal cancer (CRC) patients, and GEM inability to be commonly available in the clinic due to the lack of clarity of the exact action targets. METHODS: The half maximal inhibitory concentration (IC50) of GEM treatm...
Autores principales: | Zeng, Xinxin, Sun, Liyue, Ling, Xiaomei, Jiang, Yuying, Shen, Ju, Liang, Lei, Zhang, Xuhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471186/ https://www.ncbi.nlm.nih.gov/pubmed/37664836 http://dx.doi.org/10.3389/fendo.2023.1170526 |
Ejemplares similares
-
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy
por: Grisanti, Salvatore, et al.
Publicado: (2021) -
Comprehensive scientometrics and visualization study profiles lymphoma metabolism and identifies its significant research signatures
por: Guo, Song-Bin, et al.
Publicado: (2023) -
Optimizing strategies to identify high risk of developing type 2 diabetes
por: Bracco, Paula Andreghetto, et al.
Publicado: (2023) -
Effects of Bariatric Endoscopy on Non-Alcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Meta-Analysis
por: Ren, Mengting, et al.
Publicado: (2022) -
Novel mutations of TEX11 are associated with non-obstructive azoospermia
por: Song, Jian, et al.
Publicado: (2023)